Jaguar Health (JAGX) Consolidated Net Income (2014 - 2026)

Jaguar Health (JAGX) has 13 years of Consolidated Net Income data on file, last reported at $8.7 million in Q1 2026.

• On a quarterly basis, Consolidated Net Income rose 182.32% year-over-year to $8.7 million in Q1 2026; TTM through Mar 2026 was -$34.7 million, a 14.33% increase from a year earlier, with the FY2025 full-year figure at -$54.0 million, down 37.57% from the prior year.
• Consolidated Net Income for Q1 2026 stood at $8.7 million, up from -$23.2 million in the prior quarter.
• Over the last five years, Consolidated Net Income for JAGX reached as high as $8.7 million in Q1 2026 and fell as low as -$23.2 million in Q4 2025.
• Historically, Consolidated Net Income has averaged -$10.3 million across 5 years, with a median of -$10.0 million in 2024.
• Across the five-year window, Consolidated Net Income plunged 126.63% in 2025 and jumped 182.32% in 2026, its largest moves.
• Year by year, Consolidated Net Income stood at -$8.2 million in 2022, then declined by 13.08% to -$9.3 million in 2023, then decreased by 9.94% to -$10.2 million in 2024, then plunged by 126.63% to -$23.2 million in 2025, then surged by 137.61% to $8.7 million in 2026.
• Per Business Quant data, the three most recent Consolidated Net Income figures were $8.7 million in Q1 2026, -$23.2 million in Q4 2025, and -$9.6 million in Q3 2025.